We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+17.22%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$270M
AUM Growth
+$52.1M
Cap. Flow
+$22M
Cap. Flow %
8.14%
Top 10 Hldgs %
40.76%
Holding
941
New
464
Increased
200
Reduced
32
Closed
8

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.34M
2
XOM icon
ExxonMobil
XOM
+$1.31M
3
CVX icon
Chevron
CVX
+$1.25M
4
LLY icon
Eli Lilly
LLY
+$685K
5
JPM icon
JPMorgan Chase
JPM
+$684K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.18M
2
NVDA icon
NVIDIA
NVDA
+$618K
3
AVGO icon
Broadcom
AVGO
+$138K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$113K
5
AAPL icon
Apple
AAPL
+$105K

Sector Composition

Rank Sector Weight
1 Technology 44.15%
2 Healthcare 9.98%
3 Consumer Staples 7.57%
4 Financials 6.32%
5 Industrials 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NS
301
DELISTED
NuStar Energy L.P.
NS
$34.9K 0.01%
1,500
PNFP icon
302
Pinnacle Financial Partners Inc
PNFP
$15.5B
$34K 0.01%
+396
New +$33.3K
VYM icon
303
Vanguard High Dividend Yield ETF
VYM
$81.1B
$33.6K 0.01%
278
ECL icon
304
Ecolab
ECL
$75.6B
$33.6K 0.01%
145
IDXX icon
305
Idexx Laboratories
IDXX
$42.9B
$32.9K 0.01%
61
+21
+53% +$11.5K
DELL icon
306
Dell
DELL
$283B
$32.9K 0.01%
288
+207
+256% +$19.3K
UPS icon
307
United Parcel Service
UPS
$97.6B
$32.8K 0.01%
221
+11
+5% +$1.67K
ALB icon
308
Albemarle
ALB
$13.5B
$32.8K 0.01%
+248
New +$30.5K
LH icon
309
Labcorp
LH
$24.3B
$32.8K 0.01%
+150
New +$33K
HES
310
DELISTED
Hess
HES
$32.7K 0.01%
+214
New +$31.1K
SMG icon
311
ScottsMiracle-Gro
SMG
$4.03B
$32.1K 0.01%
+431
New +$26.8K
HII icon
312
Huntington Ingalls Industries
HII
$11.3B
$32.1K 0.01%
+110
New +$30.3K
PM icon
313
Philip Morris
PM
$301B
$32K 0.01%
+344
New +$31.7K
RSPT icon
314
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.38B
$31.7K 0.01%
900
WBS icon
315
Webster Financial
WBS
$12.3B
$31.2K 0.01%
+615
New +$30.1K
GATX icon
316
GATX Corp
GATX
$6.55B
$31K 0.01%
+230
New +$28.9K
SNY icon
317
Sanofi
SNY
$104B
$30.9K 0.01%
+636
New +$31.1K
SYY icon
318
Sysco
SYY
$39.7B
$30.7K 0.01%
+378
New +$29.8K
NFLX icon
319
Netflix
NFLX
$292B
$30.4K 0.01%
+500
New +$28.2K
IWM icon
320
iShares Russell 2000 ETF
IWM
$80.9B
$30.1K 0.01%
143
+48
+51% +$9.57K
OKE icon
321
Oneok
OKE
$58.7B
$30.1K 0.01%
+375
New +$27.4K
AGNC icon
322
AGNC Investment
AGNC
$12.3B
$30.1K 0.01%
3,000
SUSA icon
323
iShares ESG Optimized MSCI USA ETF
SUSA
$3.98B
$30K 0.01%
275
+10
+4% +$1.04K
MKC icon
324
McCormick & Company Non-Voting
MKC
$13.4B
$29.6K 0.01%
386
BAX icon
325
Baxter International
BAX
$11.6B
$29.4K 0.01%
684
+460
+205% +$18.7K

Similar funds

Front Row Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Front Row Advisors held 941 positions worth $270M, up 24% from $218M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Front Row Advisors deployed $22M of net new capital in Q1 2024, opening 464 new positions and adding to 200 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 8,008 shares worth $525K.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Pfizer, an estimated $1.18M trimmed.

  • Front Row Advisors's largest Q1 2024 buy was Vanguard Information Technology ETF: 8,008 shares worth $525K.
  • Front Row Advisors added most to Berkshire Hathaway Class B in Q1 2024, an estimated $1.34M increase.
  • Front Row Advisors's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.18M.
  • Front Row Advisors fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q1 2024, selling an estimated $16.2K.
  • Front Row Advisors's ten largest holdings make up 41% of its $270M portfolio in Q1 2024.
  • Front Row Advisors opened 464 new positions and closed 8 in Q1 2024.
  • Front Row Advisors's portfolio value rose 24% quarter-over-quarter to $270M.

Based on Front Row Advisors's 13F filing for Q1 2024, filed 14 May 2024.